Skip to content
★ Sign in to follow
RS

Robert Spurr

Président et Directeur de la Pharma
Bausch Health Companies Inc.
Total declarations
20
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (5 ops.)
€312k

Latest filing published 12 May 2022 for Bausch Health Companies Inc..

Filing timeline

BuySale
Robert Spurr

Insider track record

Disclosed buys
0
Disclosed sells
5

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Robert Spurr: trading record in brief

Robert Spurr is a declared insider of Bausch Health Companies Inc. (chief executive), with filings sourced from SEC (Form 4). In total, 20 filings cover trades dated from 28 August 2020 to 10 May 2022.

Sales make up the whole of the open-market record (5 sales, €312k). The rest of the record consists of 12 share grants and 3 option exercises. Since January 2022: no purchases and 5 sales on the market.

On 12 May 2022 came the latest disclosure, an option exercise in Bausch Health Companies Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Robert Spurr

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations11 total

11 of 11 declarations